Cross-Reactive and Cross-Neutralizing Activity of Human Mumps Antibodies Against a Novel Mumps Virus From Bats

To evaluate the antigenic relationship between bat mumps virus (BMV) and the JL5 vaccine strain of mumps virus (MuVJL5), we rescued a chimeric virus bearing the F and HN glycoproteins of BMV in the background of a recombinant JL5 genome (rMuVJL5). Cross-reactivity and cross-neutralization between this chimeric recombinant MuV bearing the F and HN glycoproteins of BMV (rMuVJL5-F/HNBMV) virus and rMuVJL5 were demonstrated using hyperimmune mouse serum samples and a curated panel of human serum. All mouse and human serum samples that were able to neutralize rMuVJL5 infection had cross-neutralizing activity against rMuVJL5-F/HNBMV. Our data suggest that persons who have neutralizing antibodies against MuV might be protected from infection by BMV..

Medienart:

E-Artikel

Erscheinungsjahr:

2017

Erschienen:

2017

Enthalten in:

Zur Gesamtaufnahme - volume:215

Sprache:

Englisch

Beteiligte Personen:

Beaty, Shannon M. [VerfasserIn]
Nachbagauer, Raffael [VerfasserIn]
Hirsh, Ariana [VerfasserIn]
Vigant, Frederic [VerfasserIn]
Duehr, James [VerfasserIn]
Azarm, Kristopher D. [VerfasserIn]
Stelfox, Alice J. [VerfasserIn]
Bowden, Thomas A. [VerfasserIn]
Duprex, W. Paul [VerfasserIn]
Krammer, Florian [VerfasserIn]
Lee, Benhur [VerfasserIn]

Links:

Volltext

Themen:

Research-article

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

JST134555201